Search for: "Hyman Phelps McNamara" Results 21 - 40 of 207
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Sep 2023, 2:23 am by Hyman Phelps McNamara
  Non-compliant facilities face: Increased patient and employee health risks — in some cases even overdose deaths Multi-million-dollar settlements — and these amounts have been increasing each year Significant long-term compliance costs to meet the requirements of government settlement agreements Erosion of public trust and confidence in affected hospitals and pharmacies Unwanted local and national publicity Hyman, Phelps & McNamara (HP&M) invites… [read post]
12 Sep 2023, 8:28 pm by Hyman Phelps McNamara
  Non-compliant facilities face: Increased patient and employee health risks — in some cases even overdose deaths Multi-million-dollar settlements — and these amounts have been increasing each year Significant long-term compliance costs to meet the requirements of government settlement agreements Erosion of public trust and confidence in affected hospitals and pharmacies Unwanted local and national publicity Hyman, Phelps & McNamara (HPM) invites you… [read post]
27 Jun 2023, 2:29 am by Hyman Phelps McNamara
Valentine Named Top Lawyer Under 40; Only Food and Drug Lawyer Selected Hyman, Phelps & McNamara, P.C. [read post]
12 Apr 2023, 5:43 pm by Hyman Phelps McNamara
On Thursday, April 20, from 1:30-3:00pm, John Claud of Hyman, Phelps & McNamara, P.C. will present a webinar entitled “Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC. [read post]
27 Mar 2023, 8:45 pm by Hyman Phelps McNamara
Thank you to those who registered for and attended Hyman, Phelps & McNamara’s March 23, 2023 lunchtime webinar addressing the “End of the COVID-19 Emergency and the Ryan Haight Act: Telemedicine and Next Steps. [read post]
19 Feb 2023, 7:44 pm by Hyman Phelps McNamara
Hyman, Phelps & McNamara (“HPM”) Director Larry Houck will present “Prescribing Red Flags, Corresponding Responsibility and DEA Investigations: What’s a Pharmacist To Do? [read post]
29 Jan 2023, 6:09 pm by Kurt R. Karst
The analysis was prepared for Pharma Conference’s conference on February 8 and 9 in San Diego (“Current Hot GMP Topics”), linked here, where Hyman, Phelps & McNamara, P.C., Director Doug Farquhar will be presenting on three areas: enforcement areas of primary concern, the conduct of internal investigations, and contacting FDA about inspections. [read post]
22 Jan 2023, 9:08 pm by Hyman Phelps McNamara
As we have done in the past for significant laws amending the operative food and drug statutes, Hyman, Phelps & McNamara, P.C. has prepared a detailed Summary and Analysis of FDORA. [read post]